Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Futura Medical ( (GB:FUM) ) has shared an update.
Futura Medical announced its total issued share capital consists of 306,120,659 Ordinary Shares, with no shares held in treasury. This information is crucial for shareholders to determine their interests in the company under FCA’s Disclosure and Transparency Rules. The announcement reflects Futura’s ongoing commitment to transparency and regulatory compliance, potentially impacting shareholder decisions and market perceptions.
The most recent analyst rating on (GB:FUM) stock is a Buy with a £140.00 price target. To see the full list of analyst forecasts on Futura Medical stock, see the GB:FUM Stock Forecast page.
More about Futura Medical
Futura Medical plc is a pharmaceutical company specializing in the development of innovative sexual health products. Their primary offerings include Eroxon®, a topical gel for erectile dysfunction, and WSD4000, a treatment for impaired sexual response in women. The company focuses on research, development, and commercialization of topically delivered gel formulations, addressing significant unmet needs in the sexual health market.
Average Trading Volume: 1,917,065
Technical Sentiment Signal: Sell
Current Market Cap: £8.09M
See more insights into FUM stock on TipRanks’ Stock Analysis page.